William Everett

Tekelec Global, Inc. provides mobile broadband solutions. The company was founded by Jean-Claude Asscher in December 1971 and was headquartered in Morrisville, NC.

Steleus Group, Inc. develops telecommunications software and hardware products and is pioneered the deployment of real-time call detail record capture and mobile messaging for the telecommunications industry through the Company's European subsidiary, NMG Telecoms. It is located in Westford, MA.

Maps a la Carte, Inc. is based in North Chelmsford, MA. Maps a la Carte, Inc. provides free access to high-quality shaded relief USGS topo maps, forest service maps, satellite images, and custom map layers online 24/7. The company was founded by William H. Everett.

Hakisa SAS develops a digital platform to connect communities. The French company was founded in 2011 by Eric Gehl and Olivier Audouze, with Eric Gehl serving as CEO since then.

Agnity Global, Inc. provides mobile communication and collaboration solutions. The firm offers cloud hosting, server management, system integration and other services. The company was founded by Sanjeev Chawla and is headquartered in Fremont, CA.

NeoNova Network Services LLC engages in provision of managed internet protocol services. Its services include Google applications for business, Microsoft office solutions for businesses, cloud files solutions, cloud hosting, cloud server solutions, and disaster recovery. The company was founded in 1999 and is headquartered in Raleigh, NC.

Epsilon Data Management LLC provides marketing and data management services. It offers multi channel marketing, technologies and database solutions, strategic consulting, and account management services. The company was founded in 1969 and is headquartered in Irving, TX.

Part of Compagnie de Saint-Gobain SA, Chemfab Corp. is an emerging biotechnology company based in Merrimack, NH that aims to accelerate patient access to transformational immunotherapies, addressing several of the most challenging unmet medical needs in cancer. The company focuses on natural killer (NK) cell biology and is leveraging multiple advanced patented technologies, including an induced pluripotent stem cell (iPSC) platform for chimeric antigen receptors (CAR) NK cell therapy, next-generation precision gene-editing to enhance targeting of NK cells, and NK engager multi-functional antibodies. The company's initial product portfolio focuses on both hematological malignancies such as multiple myeloma and solid tumors including hepatocellular carcinoma (HCC) and glioblastoma. HCC is a leading cause of cancer-related death, expected to cause 1 million deaths annually by 2030. Despite advances in immunotherapy, with current treatment options including multi-kinase inhibitors (TKI) and checkpoint inhibitors, life expectancy for patients diagnosed with HCC remains very low.